Article Details
Retrieved on: 2024-05-14 19:11:40
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Newly published in Neurology and Therapy, a network analysis of randomized controlled trials revealed that ravulizumab (Ultomiris; Alexion) was ...
Article found on: www.neurologylive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here